RxSight, Inc. (NASDAQ: RXST) reported Q3 EPS of ($0.04), $0.34 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $30.3 million versus the consensus estimate of $25.28 million.

GUIDANCE:

RxSight, Inc. sees FY2025 revenue of $125-130 million, versus the consensus of $125.9 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.